[Antilymphocyte-globulin and cytostatic therapy in the case of sympathetic ophthalmia (author's transl)].
The authors make known a combined immunosuppresive treatment in a case of sympathetic ophthalmia, which could not be healed by preliminary corticosteroid therapy. The authors recommend in addition to a high dosage of corticosteroids an optimal combination of cytostatics and administration of ALG.
D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000470:Alkaloids / Q000627:therapeutic use; D000477:Alkylating Agents / Q000627:therapeutic use; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007165:Immunosuppression Therapy; D008297:Male; D009879:Ophthalmia, Sympathetic / Q000188:drug therapy*; D013508:Ophthalmologic Surgical Procedures; D010946:Plants, Medicinal
D000305:Adrenal Cortex Hormones; D000470:Alkaloids; D000477:Alkylating Agents; D000961:Antilymphocyte Serum; D000963:Antimetabolites; D000970:Antineoplastic Agents
Die Therapie der sympathischen Ophthalmie mit Zytostatika und Antilymphozytenglobulin